4
MARKET OVERVIEW
Nanotechnology and clean-label trends drive nutraceutical innovations amid regulatory and consumer shifts.
53
4.2.1.1
INCREASED FOCUS ON PREVENTIVE CARE TO ENCOURAGE INVESTMENTS IN PRODUCTS/SOLUTIONS
4.2.1.2
ADVANCEMENTS IN NANOTECHNOLOGY EQUIPPED WITH NEW FEATURES RELATING TO NUTRACEUTICAL EXCIPIENTS
4.2.1.3
RISING INVESTMENTS IN CLEAN-LABEL AND NATURAL EXCIPIENTS DRIVEN BY REGULATORY PRESSURE AND SHIFTING CONSUMER HEALTH PREFERENCES
4.2.1.4
MANDATES ON FOOD FORTIFICATION BY GOVERNMENT ORGANIZATIONS
4.2.2.1
DECREASE IN RETURNS ON R&D INVESTMENTS AND HIGH COSTS OF CLINICAL TRIALS AND REGISTRATION
4.2.2.2
STRINGENT REGULATORY EXPECTATIONS FOR EXCIPIENT SAFETY, PURITY, AND COMPLIANCE, ADDING COMPLEXITY TO PRODUCT APPROVALS
4.2.3.1
MULTI-FUNCTIONALITIES OF EXCIPIENTS AIDING IN SAVING COSTS AND PROCESSING TIME
4.2.3.2
RISING AWARENESS OF MICRONUTRIENT DEFICIENCIES
4.2.3.3
GROWING POPULARITY OF GUMMY SUPPLEMENTS
4.2.4.1
CONSUMER SKEPTICISM ASSOCIATED WITH NUTRACEUTICAL PRODUCTS DUE TO RURAL AND SEMI-URBAN CONSUMERS’ PERCEPTION OF DIETARY SUPPLEMENTS AS PHARMACEUTICAL DRUGS
4.2.4.2
ENSURING COMPATIBILITY WITH HIGH-POTENCY ACTIVES
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Navigate competitive pressures and capitalize on rising nutraceutical demand amidst evolving global demographics.
67
5.2
PORTER’S FIVE FORCES ANALYSIS
5.2.1
INTENSITY OF COMPETITIVE RIVALRY
5.2.2
BARGAINING POWER OF SUPPLIERS
5.2.3
BARGAINING POWER OF BUYERS
5.2.4
THREAT OF SUBSTITUTES
5.2.5
THREAT OF NEW ENTRANTS
5.3
MACROECONOMIC INDICATORS
5.3.1
GLOBAL POPULATION WITNESSING HIGH PREVALENCE OF OBESITY
5.3.2
AGING POPULATION BECOMING MORE AWARE OF BENEFITS OF NUTRACEUTICALS
5.4
SUPPLY CHAIN ANALYSIS
5.5.1
SOURCING OF RAW MATERIALS
5.5.3
DISTRIBUTION, MARKETING, AND SALES
5.6.1.1
EXCIPIENT MANUFACTURERS
5.6.1.2
TECHNOLOGY PROVIDERS
5.6.2.1
REGULATORY BODIES
5.6.2.2
NUTRACEUTICAL MANUFACTURERS
5.7.1
INDICATIVE AVERAGE SELLING PRICE, BY SOURCE
5.7.2
AVERAGE SELLING PRICE TREND, BY REGION
5.8.1
TRADE ANALYSIS OF HS CODE 210690
5.8.1.1
EXPORT TRENDS OF NUTRACEUTICAL EXCIPIENT UNDER HS CODE 210690
5.8.1.2
IMPORT TRENDS OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 210690
5.8.2
TRADE ANALYSIS OF HS CODE 300490
5.8.2.1
EXPORT TRENDS OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 300490
5.8.2.2
IMPORT TRENDS OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 300490
5.8.3
TRADE ANALYSIS OF HS CODE 293090
5.8.3.1
EXPORT TRENDS OF NUTRACEUTICAL EXCIPIENT UNDER HS CODE 293090
5.8.3.2
IMPORT TRENDS OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 293090
5.8.4
TRADE ANALYSIS OF HS CODE 382200
5.8.4.1
EXPORT TRENDS OF NUTRACEUTICAL EXCIPIENT UNDER HS CODE 382200
5.8.4.2
IMPORT TRENDS OF NUTRACEUTICAL EXCIPIENT UNDER HS CODE 382200
5.9
KEY CONFERENCES & EVENTS
5.10
TRENDS IMPACTING CUSTOMERS’ BUSINESSES
5.11
INVESTMENT AND FUNDING SCENARIO
5.12.1
BENEO’S GALENIQ® MULTIFUNCTIONAL FILLER-BINDER FOR CLEAN-LABEL TABLETS (CPHI 2025)
5.12.2
ROQUETTE READILYCOAT® LOW-TEMPERATURE COATING SYSTEM (2025)
5.12.3
EVONIK – LIPID-BASED CARRIER FOR OMEGA-3 CAPSULES (APRIL 2024)
5.13
IMPACT OF 2025 US TARIFF - NUTRACEUTICAL EXCIPIENTS MARKET
5.13.3
PRICE IMPACT ANALYSIS
5.13.4
IMPACT ON COUNTRY/REGION
5.13.5
IMPACT ON END-USE INDUSTRY
6
STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS
Harness AI and patents to revolutionize nutraceutical excipients with strategic tech disruptions.
93
6.2
KEY EMERGING TECHNOLOGIES
6.3
COMPLEMENTARY TECHNOLOGIES
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.5.1
LIST OF MAJOR PATENTS
6.7
IMPACT OF AI/GEN AI ON NUTRACEUTICAL EXCIPIENTS MARKET
6.7.1
TOP USE CASES AND MARKET POTENTIAL
6.7.2
BEST PRACTICES IN NUTRACEUTICAL EXCIPIENT PROCESSING
6.7.3
CASE STUDIES OF AI IMPLEMENTATION IN NUTRACEUTICAL EXCIPIENTS MARKET
6.7.3.1
AI-DRIVEN INGREDIENT DISCOVERY & FORMULATION OPTIMIZATION
6.7.3.2
AI-ENABLED EVIDENCE REVIEW AND PRODUCT RATIONALIZATION (2025)
6.7.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.7.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN NUTRACEUTICAL EXCIPIENTS MARKET
6.8
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
Navigate global nutraceutical regulations with insights on regional compliance and sustainability initiatives.
109
7.2
REGIONAL REGULATIONS AND COMPLIANCE
7.2.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2.2.1
ORGANIZATIONS/REGULATIONS GOVERNING NUTRACEUTICAL EXCIPIENTS MARKET
7.2.2.3
EUROPEAN UNION (EU)
7.2.2.4.4
AUSTRALIA & NEW ZEALAND
7.2.2.5
REST OF THE WORLD (ROW)
7.2.2.6.2
NATIONAL/INTERNATIONAL BODIES FOR SAFETY STANDARDS AND REGULATIONS
7.2.2.6.3
CODEX ALIMENTARIUS COMMISSION (CAC)
7.2.2.6.4
NORTH AMERICA: REGULATORY ENVIRONMENT ANALYSIS
7.2.2.6.5
ASIA PACIFIC: REGULATORY ENVIRONMENT ANALYSIS
7.2.2.6.6
SOUTH AMERICA: REGULATORY ENVIRONMENT ANALYSIS
7.3
SUSTAINABILITY INITIATIVES
7.3.1
ADOPTION OF PLANT-BASED AND UPCYCLED RAW MATERIALS
7.3.2
IMPLEMENTATION OF ENERGY-EFFICIENT PROCESSING TECHNOLOGIES
7.4
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.5
CERTIFICATIONS, LABELING, ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Discover how unmet needs and stakeholder influence shape nutraceutical buying decisions and market profitability.
130
8.2
DECISION-MAKING PROCESS
8.3
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.4
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.5
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 17 Data Tables
136
9.2.1
GROWING STABILITY REQUIREMENTS OF PROBIOTIC INGREDIENTS TO DRIVE MARKET
9.3.1
INCREASING FORMULATION NEEDS FOR STABLE PREBIOTIC INGREDIENTS TO DRIVE MARKET
9.4
PROTEINS & AMINO ACIDS
9.4.1
GROWING FORMULATION REQUIREMENTS FOR STABLE PROTEIN AND AMINO ACID INGREDIENTS TO DRIVE MARKET
9.5.1
PREVALENCE OF VITAMIN DEFICIENCIES AMONG CONSUMERS TO DRIVE MARKET GROWTH FOR NUTRACEUTICAL EXCIPIENTS
9.6.1
BENEFITS OFFERED FOR OPTIMAL FUNCTIONING OF BRAIN AND HEART TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET
9.7.1
INCREASE IN HEART DISEASES TO DRIVE DEMAND FOR OMEGA-3 FATTY ACID SUPPLEMENTS
10
NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 24 Data Tables
148
10.2.1.1.1
NEED FOR ENHANCING TEXTURE AND CREAMINESS LIKELY TO PROPEL DEMAND
10.2.1.2
MINERAL STEARATES
10.2.1.2.1
MINERAL STEARATES TO REDUCE FRICTION AND AVOID EQUIPMENT CLOGGING DURING MANUFACTURING OF NUTRACEUTICALS
10.2.1.3.1
GLYCERIN TO HELP IMPROVE SMOOTHNESS AND LUBRICATION PROCESS
10.2.1.4
OTHER OLEOCHEMICALS
10.2.2.1.2
SUGAR ALCOHOLS
10.2.2.1.3
ARTIFICIAL SWEETENERS
10.2.2.2.1
MICROCRYSTALLINE CELLULOSE
10.2.2.2.2
CELLULOSE ETHERS
10.2.2.2.3
CMC & CROSCARMELLOSE SODIUM
10.2.2.2.4
CELLULOSE ESTERS
10.2.2.3.1
MODIFIED STARCH
10.2.2.3.3
CONVERTED STARCH
10.2.3.1.1
HUMECTANT & SOLVENT PROPERTIES TO DRIVE DEMAND
10.2.3.2.1
FILM-FORMING FUNCTION TO PROVIDE CONTROLLED RELEASE OF ACTIVE INGREDIENTS
10.2.3.3
MINERAL HYDROCARBONS
10.2.3.3.1
PROPERTIES SUCH AS ANTIFOAMING AND LUBRICATION TO HELP IN NUTRACEUTICAL MANUFACTURING
10.2.3.4
ACRYLIC POLYMERS
10.2.3.4.1
DIVERSE FUNCTIONS OF ACRYLIC POLYMERS IN NUTRACEUTICALS TO PROPEL GROWTH
10.2.3.5
OTHER PETROCHEMICAL EXCIPIENTS
10.2.4.1
EXPANDING UTILIZATION OF PROTEINS AS CARRIERS FOR MICROPARTICLES AND NANOPARTICLES TO PROPEL MARKET GROWTH
10.2.5
OTHER ORGANIC CHEMICALS
10.3.1.1
NUTRACEUTICAL PRODUCTION TO BE OPTIMIZED BY UTILIZING GMO-FREE CALCIUM PHOSPHATES AS GRAS EXCIPIENTS
10.3.2.1
METAL OXIDES TO HELP MEET RISING DEMAND FOR IRON-ENRICHED NUTRACEUTICALS
10.3.3.1
HALITES TO ENSURE TASTE IMPROVEMENT AND SALTING-OUT TECHNIQUES
10.3.4.1
FOCUS ON R&D OF CALCIUM CARBONATE TO HELP LAUNCH NEW PRODUCTS
10.3.5.1
IMPROVED FLOWABILITY TO DRIVE DEMAND FOR CALCIUM SULFATE
10.3.6
OTHER INORGANIC CHEMICALS
11
NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 12 Data Tables
170
11.2.1
CREATING DIFFERENTIATION IS KEY IN THIS COMPETITIVE MARKET
11.3.1
MAINTAINING DESIRABLE PROPERTIES UNTIL CONSUMPTION TO DRIVE DEMAND FOR STABILIZERS
11.4.1
NEED FOR SLOWER AND STEADIER RELEASE OF COMPOUNDS TO PROPEL GROWTH OF MODIFIED-RELEASE APPLICATIONS IN NUTRACEUTICAL EXCIPIENTS MARKET
11.5
SOLUBILITY & BIOAVAILABILITY ENHANCEMENT
11.5.1
CHALLENGES RELATED TO POOR SOLUBILITY AND LIMITED ABSORPTION OF BIOACTIVE COMPOUNDS TO DRIVE DEMAND
11.6
OTHER FUNCTIONALITY APPLICATIONS
12
NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 10 Data Tables
178
12.2.1.1
EASY-TO-CARRY AND PORTABLE NATURE MAKES THEM ATTRACTIVE OPTION
12.2.2.1
QUICK-DISSOLVING CAPSULE SHELLS FOR TARGETED ABSORPTION ARE IDEAL FOR NUTRACEUTICALS DESIGNED TO ACT IN SPECIFIC AREAS OF DIGESTIVE TRACT
12.3.1
POTENTIAL GROWTH OPPORTUNITIES FOR LIQUID NUTRACEUTICAL EXCIPIENTS DUE TO INNOVATIONS IN FORMULATIONS TO DRIVE GROWTH
13
NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 24 Data Tables
185
13.2.1
INCREASED ACCEPTANCE AND USE OF BINDING AGENTS IN PRODUCTS TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET
13.3.1
USE OF ACTIVE INGREDIENTS IN NUTRACEUTICAL PRODUCTS TO ENCOURAGE USE OF FILLERS AND DILUENTS AS EXCIPIENTS
13.4.1
HIGH CONSUMPTION OF DIETARY SUPPLEMENTS IN FORM OF ORAL DOSAGES OR TABLETS TO DRIVE GROWTH OF DISINTEGRANTS SEGMENT
13.5.1
PROTECTION FROM MOISTURE AND BACTERIA TO DRIVE DEMAND
13.6
FLAVORING AGENTS & SWEETENERS
13.6.1
INCREASE IN NEED FOR MASKING STRONG AND UNAPPEALING FLAVORS TO DRIVE GROWTH OF SEGMENT
13.7.1
INHIBITION OF MICROBIAL GROWTH AND MAINTAINING PRODUCT QUALITY AND SAFETY TO DRIVE DEMAND FOR PRESERVATIVES
13.8
LUBRICANTS & GLIDANTS
13.8.1
INCREASE IN NEED FOR REDUCING FRICTION AND KEEPING FORMULATION INTACT DURING PRODUCTION PROCESS TO DRIVE GROWTH OF SEGMENT
13.9
SUSPENDING & VISCOSITY AGENTS
13.9.1
PREVENTING SETTLING TO HELP MAINTAIN HOMOGENEITY AND STABILITY OF PRODUCT
13.10.1
NEED FOR VISUAL APPEAL AND PRODUCT DIFFERENTIATION TO FUEL DEMAND FOR COLORANTS
13.11.1
NEED FOR REDUCING SURFACE TENSION BETWEEN DIFFERENT COMPONENTS TO DRIVE DEMAND FOR EMULSIFYING AGENTS
13.12
OTHER FUNCTIONALITIES
14
NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION
Comprehensive coverage of 9 Regions with country-level deep-dive of 14 Countries | 102 Data Tables.
200
14.2.1.1
HIGH CONCENTRATION OF KEY PLAYERS, VARIOUS NUTRITION AWARENESS PROGRAMS, AND INCREASE IN PREVENTIVE HEALTHCARE TRENDS IN US
14.2.2.1
DEMAND FOR QUALITY AND COST-COMPETITION: TWO KEY FACTORS FOR MANUFACTURERS TO CONSIDER IN CANADA
14.2.3.1
INCREASE IN FOREIGN DIRECT INVESTMENTS AND RISE IN AWARENESS REGARDING HEALTHIER LIFESTYLES ASSOCIATED WITH DIETARY SUPPLEMENTS
14.3.1.1
DEMAND FOR NUTRACEUTICAL EXCIPIENTS IS LIKELY TO INCREASE TO SERVE HEALTH-CONSCIOUS CONSUMERS
14.3.2.1
INNOVATIONS IN PRODUCT FORMULATIONS TO CATER TO INCREASED CONSUMER DEMANDS
14.3.3.1
GROWTH OF FUNCTIONAL/FORTIFIED FOOD & BEVERAGE INDUSTRY IN UK TO DRIVE DEMAND FOR NUTRACEUTICAL EXCIPIENTS
14.3.4.1
GROWING TREND OF ONLINE OTC AND FOOD SUPPLEMENT PURCHASES IN ITALY
14.3.5.1
EXCIPIENT MANUFACTURERS EXPAND IBERIAN OPERATIONS TO SUPPORT TABLETS AND CAPSULES MARKETED ACROSS SPAIN
14.4.1.1
RISE IN PREFERENCE FOR NUTRACEUTICAL PRODUCTS AND INNOVATIONS IN DIETARY SUPPLEMENT FORMULATIONS AND FORTIFIED FOOD PRODUCTS
14.4.2.1
MANUFACTURERS SHOULD THINK BEYOND PILLS & INNOVATION TO TAP THIS GROWING MARKET IN JAPAN
14.4.3.1
GOVERNMENT POLICIES AND IMPORTANCE OF NUTRACEUTICALS IN DAILY LIFE
14.4.4.1
RAPID GROWTH OF SUPPLEMENTS INDUSTRY IN SOUTH KOREA
14.4.5
REST OF ASIA PACIFIC
14.5.1.1
GROWTH IN AWARENESS REGARDING THE BENEFITS OF FUNCTIONAL FOODS AND RISE IN AGING POPULATION IN BRAZIL
14.5.2.1
COUNTRY’S FOCUS ON PREVENTION HEALTHCARE SYSTEM TO BE POSITIVE SIGN FOR NUTRACEUTICAL EXCIPIENTS MARKET
14.5.3
REST OF SOUTH AMERICA
14.6
REST OF THE WORLD (ROW)
14.6.1.1
RISE IN OBESITY AND OTHER HEALTH-RELATED CONCERNS IN MIDDLE EAST
14.6.2.1
INTRA-AFRICAN TRADE POLICIES AND INVESTMENTS BY GLOBAL NUTRACEUTICAL PLAYERS
15
COMPETITIVE LANDSCAPE
Discover market leaders' strategies and performance metrics shaping competitive dynamics through 2024.
258
15.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2020–2024
15.3
REVENUE ANALYSIS, 2022–2024
15.4
MARKET SHARE ANALYSIS, 2024
15.5
BRAND/PRODUCT COMPARISON
15.5.1
KERRY GROUP PLC (IRELAND)
15.5.4
ASSOCIATED BRITISH FOODS PLC (UK)
15.5.5
SENSIENT TECHNOLOGIES CORPORATION (US)
15.6
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
15.6.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
15.6.5.1
COMPANY FOOTPRINT
15.6.5.2
REGION FOOTPRINT
15.6.5.3
SOURCE FOOTPRINT
15.6.5.4
FUNCTIONALITY FOOTPRINT
15.6.5.5
FUNCTIONALITY APPLICATION FOOTPRINT
15.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
15.7.1
PROGRESSIVE COMPANIES
15.7.2
RESPONSIVE COMPANIES
15.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
15.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
15.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
15.8
COMPANY VALUATION AND FINANCIAL METRICS
15.9
COMPETITIVE SCENARIO
15.9.4
OTHER DEVELOPMENTS
16
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
284
16.1.1.1
BUSINESS OVERVIEW
16.1.1.2
PRODUCT/SOLUTIONS/SERVICES OFFERED
16.1.1.3
RECENT DEVELOPMENTS
16.1.1.4.2
STRATEGIC CHOICES
16.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
16.1.4
ASSOCIATED BRITISH FOODS PLC
16.1.5
SENSIENT TECHNOLOGIES CORPORATION
16.1.6
CARGILL, INCORPORATED
16.1.15
HILMAR CHEESE COMPANY, INC.
16.1.20
NOVO EXCIPIENTS PVT. LTD.
16.1.21
PANCHAMRUT CHEMICALS
16.1.23
FUJI CHEMICAL INDUSTRIES CO., LTD.
16.1.24
SUDEEP PHARMA LIMITED
16.1.25
SORSE TECHNOLOGIES
17
RESEARCH METHODOLOGY
378
17.1.1.1
KEY DATA FROM SECONDARY SOURCES
17.1.2.1
KEY DATA FROM PRIMARY SOURCES
17.1.2.2
KEY PRIMARY PARTICIPANTS
17.1.2.2.1
NUTRACEUTICAL EXCIPIENTS COMPANIES
17.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
17.1.2.4
KEY INDUSTRY INSIGHTS
17.2
MARKET SIZE ESTIMATION
17.2.1
BOTTOM-UP APPROACH
17.5
RESEARCH ASSUMPTIONS
17.6
RESEARCH LIMITATIONS
18.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
TABLE 1
INCLUSIONS AND EXCLUSIONS
TABLE 2
USD EXCHANGE RATES, 2020–2024
TABLE 3
GLOBAL PREVALENCE OF ANEMIA, 2024–2025
TABLE 4
UNMET NEEDS AND WHITE SPACES IN NUTRACEUTICAL EXCIPIENTS MARKET
TABLE 5
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
TABLE 6
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
TABLE 7
NUTRACEUTICAL EXCIPIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 8
NUTRACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM
TABLE 9
INDICATIVE AVERAGE SELLING PRICE (ASP) OF NUTRACEUTICAL EXCIPIENTS BY KEY PLAYERS, 2024 (USD/MT)
TABLE 10
INDICATIVE PRICING ANALYSIS FOR NUTRACEUTICAL EXCIPIENTS, BY SOURCE, 2023–2024 (USD/KG)
TABLE 11
AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2024 (USD/KG)
TABLE 12
NUTRACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026
TABLE 13
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 14
EXPECTED IMPACT LEVEL ON TARGET PRODUCTS WITH RELEVANT HS CODES DUE TO TRUMP TARIFF IMPACT
TABLE 15
EXPECTED TARIFF IMPACT ON END-USE INDUSTRIES: NUTRACEUTICAL EXCIPIENT
TABLE 16
TECHNOLOGY/PRODUCT MAP FOR NUTRACEUTICAL EXCIPIENTS MARKET
TABLE 17
LIST OF MAJOR PATENTS ABOUT NUTRACEUTICAL EXCIPIENTS MARKET, 2021–2024
TABLE 18
NUTRACEUTICAL EXCIPIENTS MARKET: FUTURE APPLICATIONS
TABLE 19
NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20
EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21
ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22
SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23
ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24
DEFINITIONS & REGULATIONS FOR NUTRACEUTICAL EXCIPIENTS WORLDWIDE
TABLE 25
DEFINITIONS & REGULATIONS FOR NUTRACEUTICALS WORLDWIDE
TABLE 26
SCHEDULE – XI OF FOOD SAFETY AND STANDARDS REGULATIONS, 2015, FOR LIST OF APPROVED PREBIOTIC EXCIPIENTS
TABLE 27
LIST OF ACCEPTED DIETARY FIBERS BY CANADIAN REGULATORY AUTHORITIES & THEIR SOURCES
TABLE 28
KEY INDUSTRY STANDARDS FOR NUTRACEUTICAL EXCIPIENTS MARKET
TABLE 29
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR NUTRACEUTICAL EXCIPIENT SOURCE
TABLE 30
KEY BUYING CRITERIA FOR NUTRACEUTICAL EXCIPIENT END PRODUCT
TABLE 31
NUTRACEUTICAL EXCIPIENTS MARKET, BY MATERIAL, 2020–2024 (USD MILLION)
TABLE 32
NUTRACEUTICAL EXCIPIENTS MARKET, BY MATERIAL, 2025–2030 (USD MILLION)
TABLE 33
NUTRACEUTICAL EXCIPIENTS MARKET IN PROBIOTICS, BY REGION, 2020–2024 (USD MILLION)
TABLE 34
NUTRACEUTICAL EXCIPIENTS MARKET IN PROBIOTICS, BY REGION, 2025–2030 (USD MILLION)
TABLE 35
NUTRACEUTICAL EXCIPIENTS MARKET IN PREBIOTICS, BY REGION, 2020–2024 (USD MILLION)
TABLE 36
NUTRACEUTICAL EXCIPIENTS MARKET IN PREBIOTICS, BY REGION, 2025–2030 (USD MILLION)
TABLE 37
NUTRACEUTICAL EXCIPIENTS MARKET IN PROTEINS & AMINO ACIDS, BY REGION, 2020–2024 (USD MILLION)
TABLE 38
NUTRACEUTICAL EXCIPIENTS MARKET IN PROTEINS & AMINO ACIDS, BY REGION, 2025–2030 (USD MILLION)
TABLE 39
LIST OF NUTRIENTS AND THEIR RELEVANCE
TABLE 40
NUTRACEUTICAL EXCIPIENTS MARKET IN VITAMINS, BY REGION, 2020–2024 (USD MILLION)
TABLE 41
NUTRACEUTICAL EXCIPIENTS MARKET IN VITAMINS, BY REGION, 2025–2030 (USD MILLION)
TABLE 42
NUTRACEUTICAL EXCIPIENTS MARKET IN MINERALS, BY REGION, 2020–2024 (USD MILLION)
TABLE 43
NUTRACEUTICAL EXCIPIENTS MARKET IN MINERALS, BY REGION, 2025–2030 (USD MILLION)
TABLE 44
NUTRACEUTICAL EXCIPIENTS MARKET IN OMEGA-3 FATTY ACIDS, BY REGION, 2020–2024 (USD MILLION)
TABLE 45
NUTRACEUTICAL EXCIPIENTS MARKET IN OMEGA-3 FATTY ACIDS, BY REGION, 2025–2030 (USD MILLION)
TABLE 46
NUTRACEUTICAL EXCIPIENTS MARKET IN OTHER END PRODUCTS, BY REGION, 2020–2024 (USD MILLION)
TABLE 47
NUTRACEUTICAL EXCIPIENTS MARKET IN OTHER END PRODUCTS, BY REGION, 2025–2030 (USD MILLION)
TABLE 48
NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION)
TABLE 49
NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 50
ORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 51
ORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 52
ORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2020–2024 (USD MILLION)
TABLE 53
ORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2025–2030 (USD MILLION)
TABLE 54
OLEOCHEMICAL NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION)
TABLE 55
OLEOCHEMICAL NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION)
TABLE 56
CARBOHYDRATE-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION)
TABLE 57
CARBOHYDRATE-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION)
TABLE 58
SUGAR-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION)
TABLE 59
SUGAR-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION)
TABLE 60
CELLULOSE-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION)
TABLE 61
CELLULOSE-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION)
TABLE 62
STARCH-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION)
TABLE 63
STARCH-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION)
TABLE 64
PETROCHEMICAL NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION)
TABLE 65
PETROCHEMICAL NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION)
TABLE 66
INORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 67
INORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 68
INORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION)
TABLE 69
INORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION)
TABLE 70
OTHER CHEMICAL-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 71
OTHER CHEMICAL-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 72
NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION)
TABLE 73
NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION)
TABLE 74
NUTRACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY REGION, 2020–2024 (USD MILLION)
TABLE 75
NUTRACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY REGION, 2025–2030 (USD MILLION)
TABLE 76
NUTRACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY REGION, 2020–2024 (USD MILLION)
TABLE 77
NUTRACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY REGION, 2025–2030 (USD MILLION)
TABLE 78
NUTRACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY REGION, 2020–2024 (USD MILLION)
TABLE 79
NUTRACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY REGION, 2025–2030 (USD MILLION)
TABLE 80
NUTRACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY ENHANCEMENT, BY REGION, 2020–2024 (USD MILLION)
TABLE 81
NUTRACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY ENHANCEMENT, BY REGION, 2025–2030 (USD MILLION)
TABLE 82
NUTRACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY REGION, 2020–2024 (USD MILLION)
TABLE 83
NUTRACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY REGION, 2025–2030 (USD MILLION)
TABLE 84
NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION)
TABLE 85
NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION)
TABLE 86
DRY NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 87
DRY NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 88
DRY NUTRACEUTICAL EXCIPIENTS MARKET, BY DRY FORMULATION, 2020–2024 (USD MILLION)
TABLE 89
DRY NUTRACEUTICAL EXCIPIENTS MARKET, BY DRY FORMULATION, 2025–2030 (USD MILLION)
TABLE 90
LIQUID NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 91
LIQUID NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 92
OTHER NUTRACEUTICAL EXCIPIENT FORMULATIONS MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 93
OTHER NUTRACEUTICAL EXCIPIENT FORMULATIONS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 94
NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 95
NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 96
NUTRACEUTICAL EXCIPIENTS MARKET IN BINDERS, BY REGION, 2020–2024 (USD MILLION)
TABLE 97
NUTRACEUTICAL EXCIPIENTS MARKET IN BINDERS, BY REGION, 2025–2030 (USD MILLION)
TABLE 98
NUTRACEUTICAL EXCIPIENTS MARKET IN FILLERS & DILUENTS, BY REGION, 2020–2024 (USD MILLION)
TABLE 99
NUTRACEUTICAL EXCIPIENTS MARKET IN FILLERS & DILUENTS, BY REGION, 2025–2030 (USD MILLION)
TABLE 100
NUTRACEUTICAL EXCIPIENTS MARKET IN DISINTEGRANTS, BY REGION, 2020–2024 (USD MILLION)
TABLE 101
NUTRACEUTICAL EXCIPIENTS MARKET IN DISINTEGRANTS, BY REGION, 2025–2030 (USD MILLION)
TABLE 102
NUTRACEUTICAL EXCIPIENTS MARKET IN COATING AGENTS, BY REGION, 2020–2024 (USD MILLION)
TABLE 103
NUTRACEUTICAL EXCIPIENTS MARKET IN COATING AGENTS, BY REGION, 2025–2030 (USD MILLION)
TABLE 104
NUTRACEUTICAL EXCIPIENTS MARKET IN FLAVORING AGENTS & SWEETENERS, BY REGION, 2020–2024 (USD MILLION)
TABLE 105
NUTRACEUTICAL EXCIPIENTS MARKET IN FLAVORING AGENTS & SWEETENERS, BY REGION, 2025–2030 (USD MILLION)
TABLE 106
NUTRACEUTICAL EXCIPIENTS MARKET IN PRESERVATIVES, BY REGION, 2020–2024 (USD MILLION)
TABLE 107
NUTRACEUTICAL EXCIPIENTS MARKET IN PRESERVATIVES, BY REGION, 2025–2030 (USD MILLION)
TABLE 108
NUTRACEUTICAL EXCIPIENTS MARKET IN LUBRICANTS & GLIDANTS, BY REGION, 2020–2024 (USD MILLION)
TABLE 109
NUTRACEUTICAL EXCIPIENTS MARKET IN LUBRICANTS & GLIDANTS, BY REGION, 2025–2030 (USD MILLION)
TABLE 110
NUTRACEUTICAL EXCIPIENTS MARKET IN SUSPENDING & VISCOSITY AGENTS, BY REGION, 2020–2024 (USD MILLION)
TABLE 111
NUTRACEUTICAL EXCIPIENTS MARKET IN SUSPENDING & VISCOSITY AGENTS, BY REGION, 2025–2030 (USD MILLION)
TABLE 112
NUTRACEUTICAL EXCIPIENTS MARKET IN COLORANTS, BY REGION, 2020–2024 (USD MILLION)
TABLE 113
NUTRACEUTICAL EXCIPIENTS MARKET IN COLORANTS, BY REGION, 2025–2030 (USD MILLION)
TABLE 114
NUTRACEUTICAL EXCIPIENTS MARKET IN EMULSIFYING AGENTS, BY REGION, 2020–2024 (USD MILLION)
TABLE 115
NUTRACEUTICAL EXCIPIENTS MARKET IN EMULSIFYING AGENTS, BY REGION, 2025–2030 (USD MILLION)
TABLE 116
NUTRACEUTICAL EXCIPIENTS MARKET IN OTHER FUNCTIONALITIES, BY REGION, 2020–2024 (USD MILLION)
TABLE 117
NUTRACEUTICAL EXCIPIENTS MARKET IN OTHER FUNCTIONALITIES, BY REGION, 2025–2030 (USD MILLION)
TABLE 118
NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 119
NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 120
NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (KT)
TABLE 121
NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (KT)
TABLE 122
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 123
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 124
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION)
TABLE 125
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 126
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 127
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 128
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION)
TABLE 129
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION)
TABLE 130
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2020–2024 (USD MILLION)
TABLE 131
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2025–2030 (USD MILLION)
TABLE 132
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION)
TABLE 133
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION)
TABLE 134
US: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 135
US: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 136
CANADA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 137
CANADA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 138
MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 139
MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 140
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 141
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 142
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION)
TABLE 143
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 144
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 145
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 146
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION)
TABLE 147
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION)
TABLE 148
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2020–2024 (USD MILLION)
TABLE 149
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2025–2030 (USD MILLION)
TABLE 150
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION)
TABLE 151
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION)
TABLE 152
GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 153
GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 154
FRANCE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 155
FRANCE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 156
UK: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 157
UK: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 158
ITALY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 159
ITALY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 160
SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 161
SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 162
REST OF EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 163
REST OF EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 164
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 165
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 166
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION)
TABLE 167
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 168
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 169
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 170
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION)
TABLE 171
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION)
TABLE 172
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2020–2024 (USD MILLION)
TABLE 173
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2025–2030 (USD MILLION)
TABLE 174
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION)
TABLE 175
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION)
TABLE 176
CHINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 177
CHINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 178
JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 179
JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 180
INDIA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 181
INDIA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 182
SOUTH KOREA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 183
SOUTH KOREA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 184
REST OF ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 185
REST OF ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 186
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 187
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
TABLE 188
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION)
TABLE 189
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 190
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 191
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 192
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION)
TABLE 193
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION)
TABLE 194
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2020–2024 (USD MILLION)
TABLE 195
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2025–2030 (USD MILLION)
TABLE 196
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION)
TABLE 197
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION)
TABLE 198
BRAZIL: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 199
BRAZIL: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 200
ARGENTINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 201
ARGENTINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 202
REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 203
REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 204
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION)
TABLE 205
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION)
TABLE 206
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION)
TABLE 207
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
TABLE 208
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 209
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 210
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION)
TABLE 211
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION)
TABLE 212
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2020–2024 (USD MILLION)
TABLE 213
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2025–2030 (USD MILLION)
TABLE 214
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION)
TABLE 215
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION)
TABLE 216
MIDDLE EAST: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 217
MIDDLE EAST: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 218
AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
TABLE 219
AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
TABLE 220
COMPETITIVE STRATEGIES ADOPTED BY KEY PLAYERS IN NUTRACEUTICAL EXCIPIENTS MARKET, 2020–2024
TABLE 221
NUTRACEUTICAL EXCIPIENTS MARKET: DEGREE OF COMPETITION
TABLE 222
NUTRACEUTICAL EXCIPIENTS MARKET: REGION FOOTPRINT
TABLE 223
NUTRACEUTICAL EXCIPIENTS MARKET: SOURCE FOOTPRINT
TABLE 224
NUTRACEUTICAL EXCIPIENTS MARKET: FUNCTIONALITY FOOTPRINT
TABLE 225
NUTRACEUTICAL EXCIPIENTS MARKET: FUNCTIONALITY APPLICATION FOOTPRINT
TABLE 226
NUTRACEUTICAL EXCIPIENTS MARKET: KEY STARTUPS/SMES
TABLE 227
NUTRACEUTICAL EXCIPIENTS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024
TABLE 228
NUTRACEUTICAL EXCIPIENTS MARKET: PRODUCT LAUNCHES, 2020–NOVEMBER 2025
TABLE 229
NUTRACEUTICAL EXCIPIENTS MARKET: DEALS, 2020–NOVEMBER 2025
TABLE 230
NUTRACEUTICAL EXCIPIENTS MARKET: EXPANSIONS, 2020–NOVEMBER 2025
TABLE 231
NUTRACEUTICAL EXCIPIENTS MARKET: OTHER DEVELOPMENTS, 2020–NOVEMBER 2025
TABLE 232
KERRY GROUP PLC: BUSINESS OVERVIEW
TABLE 233
KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 234
KERRY GROUP PLC: DEALS
TABLE 235
KERRY GROUP PLC: EXPANSION
TABLE 236
INGREDION: BUSINESS OVERVIEW
TABLE 237
INGREDION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 238
INGREDION: DEALS
TABLE 239
BASF SE: BUSINESS OVERVIEW
TABLE 240
BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 242
BASF SE: OTHER DEVELOPMENTS
TABLE 243
ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW
TABLE 244
ASSOCIATED BRITISH FOODS PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 245
ASSOCIATED BRITISH FOODS PLC: PRODUCT LAUNCHES
TABLE 246
SENSIENT TECHNOLOGIES CORPORATION: BUSINESS OVERVIEW
TABLE 247
SENSIENT TECHNOLOGIES CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 248
SENSIENT TECHNOLOGIES CORPORATION: DEALS
TABLE 249
CARGILL, INCORPORATED: BUSINESS OVERVIEW
TABLE 250
CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 251
CARGILL, INCORPORATED: EXPANSIONS
TABLE 252
AZELIS: BUSINESS OVERVIEW
TABLE 253
AZELIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 255
AZELIS: EXPANSIONS
TABLE 256
ASHLAND: BUSINESS OVERVIEW
TABLE 257
ASHLAND: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 258
ASHLAND: PRODUCT LAUNCHES
TABLE 259
ASHLAND: OTHER DEVELOPMENTS
TABLE 260
MEGGLE HOLDING SE: BUSINESS OVERVIEW
TABLE 261
MEGGLE HOLDING SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 262
MEGGLE HOLDING SE: PRODUCT LAUNCHES
TABLE 263
ROQUETTE FRÈRES: BUSINESS OVERVIEW
TABLE 264
ROQUETTE FRÈRES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 265
ROQUETTE FRÈRES: PRODUCT LAUNCHES
TABLE 266
ROQUETTE FRÈRES: DEALS
TABLE 267
ROQUETTE FRÈRES: EXPANSIONS
TABLE 268
COLORCON, INC.: BUSINESS OVERVIEW
TABLE 269
COLORCON, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 270
COLORCON, INC.: PRODUCT LAUNCHES
TABLE 271
COLORCON, INC.: DEALS
TABLE 272
COLORCON, INC.: EXPANSIONS
TABLE 273
COLORCON, INC.: OTHER DEVELOPMENTS
TABLE 274
ALSIANO A/S: BUSINESS OVERVIEW
TABLE 275
ALSIANO A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 276
ALSIANO A/S: DEALS
TABLE 277
JIGS CHEMICAL: BUSINESS OVERVIEW
TABLE 278
JIGS CHEMICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 279
IMCD: BUSINESS OVERVIEW
TABLE 280
IMCD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 282
IMCD: EXPANSIONS
TABLE 283
HILMAR CHEESE COMPANY, INC.: BUSINESS OVERVIEW
TABLE 284
HILMAR CHEESE COMPANY, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 285
HILMAR CHEESE COMPANY, INC.: EXPANSIONS
TABLE 286
OMYA: BUSINESS OVERVIEW
TABLE 287
OMYA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 289
BIOGRUND: BUSINESS OVERVIEW
TABLE 290
BIOGRUND: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 291
BIOGRUND: DEALS
TABLE 292
BIOGRUND: EXPANSIONS
TABLE 293
JRS PHARMA: BUSINESS OVERVIEW
TABLE 294
JRS PHARMA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 295
JRS PHARMA: PRODUCT LAUNCHES
TABLE 296
JRS PHARMA: EXPANSIONS
TABLE 297
INNOPHOS: BUSINESS OVERVIEW
TABLE 298
INNOPHOS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 299
INNOPHOS: EXPANSIONS
TABLE 300
NOVO EXCIPIENTS PVT. LTD.: BUSINESS OVERVIEW
TABLE 301
NOVO EXCIPIENTS PVT. LTD.: PRODUCTS OFFERED
TABLE 302
PANCHAMRUT CHEMICALS: COMPANY OVERVIEW
TABLE 303
GATTEFOSSÉ: COMPANY OVERVIEW
TABLE 304
FUJI CHEMICAL INDUSTRIES CO., LTD.: COMPANY OVERVIEW
TABLE 305
SUDEEP PHARMA LIMITED: COMPANY OVERVIEW
TABLE 306
SORSE TECHNOLOGIES: COMPANY OVERVIEW
FIGURE 1
NUTRACEUTICAL EXCIPIENTS MARKET SEGMENTATION
FIGURE 2
STUDY YEARS CONSIDERED
FIGURE 3
KEY INSIGHTS AND MARKET HIGHLIGHTS
FIGURE 4
GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, 2021–2030 (USD MILLION)
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NUTRACEUTICAL EXCIPIENTS MARKET, 2020–2025
FIGURE 6
DISRUPTIVE TRENDS IMPACTING GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET DURING FORECAST PERIOD
FIGURE 7
HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN NUTRACEUTICAL EXCIPIENTS MARKET, 2025–2030
FIGURE 8
ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 9
INCREASING DEMAND FOR HIGH-QUALITY EXCIPIENTS ENABLING EFFECTIVE TABLET AND CAPSULE NUTRACEUTICAL FORMULATIONS
FIGURE 10
ORGANIC CHEMICALS SEGMENT AND NORTH AMERICA ACCOUNTED FOR LARGEST SEGMENTAL SHARES IN 2024
FIGURE 11
NORTH AMERICA DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024
FIGURE 12
DRY SEGMENT DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024
FIGURE 13
ORGANIC CHEMICALS SEGMENT DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024
FIGURE 14
MODIFIED RELEASE SEGMENTS DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024
FIGURE 15
PROBIOTICS SEGMENT DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024
FIGURE 16
INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 17
NUTRACEUTICAL EXCIPIENTS MARKET DYNAMICS
FIGURE 18
NUMBER OF AMERICANS WITH CHRONIC CONDITIONS, 1995–2030 (MILLION)
FIGURE 19
PORTER’S FIVE FORCES ANALYSIS: NUTRACEUTICAL EXCIPIENTS MARKET
FIGURE 20
US: POPULATION AGED 65 AND OLDER, 2000–2060 (MILLION)
FIGURE 21
KEY MARKET DRIVERS SHAPING INNOVATION, ADOPTION, AND GROWTH DYNAMICS ACROSS GLOBAL NUTRACEUTICAL EXCIPIENT INDUSTRY IN RESPONSE TO EVOLVING FORMULATION DEMANDS
FIGURE 22
NUTRACEUTICAL EXCIPIENTS MARKET: VALUE CHAIN ANALYSIS
FIGURE 23
NUTRACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM
FIGURE 24
AVERAGE SELLING PRICE TREND, BY REGION, 2020–2024 (USD/KG)
FIGURE 25
EXPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 210690 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
FIGURE 26
IMPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 210690 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
FIGURE 27
EXPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 300490 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
FIGURE 28
IMPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 300490 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
FIGURE 29
EXPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 293090 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
FIGURE 30
IMPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 293090 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
FIGURE 31
EXPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 382200 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
FIGURE 32
IMPORT VALUE OF NUTRACEUTICAL EXCIPIENT UNDER HS CODE 382200 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
FIGURE 33
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS
FIGURE 34
INVESTMENT AND FUNDING SCENARIO, 2020–2025 (USD MILLION)
FIGURE 35
NUMBER OF PATENTS GRANTED FOR NUTRACEUTICAL EXCIPIENTS MARKET, 2014–2024
FIGURE 36
REGIONAL ANALYSIS OF PATENTS GRANTED FOR NUTRACEUTICAL EXCIPIENTS MARKET, 2014–2024
FIGURE 37
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR NUTRACEUTICAL EXCIPIENT TYPE
FIGURE 38
KEY BUYING CRITERIA FOR NUTRACEUTICAL EXCIPIENT END PRODUCT
FIGURE 39
PROTEIN & AMINO ACIDS TO LEAD DURING FORECAST PERIOD
FIGURE 40
NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION)
FIGURE 41
NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025 VS. 2030
FIGURE 42
NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025 VS. 2030 (USD MILLION)
FIGURE 43
NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025 VS. 2030 (USD MILLION)
FIGURE 44
ITALY, CHINA, INDIA, AND SOUTH KOREA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 45
NORTH AMERICA: MARKET SNAPSHOT
FIGURE 46
ASIA PACIFIC: MARKET SNAPSHOT
FIGURE 47
NUTRACEUTICAL EXCIPIENTS MARKET: REVENUE ANALYSIS FOR FIVE KEY PLAYERS, 2022–2024 (USD BILLION)
FIGURE 48
SHARE OF LEADING COMPANIES IN NUTRACEUTICAL EXCIPIENTS MARKET, 2024
FIGURE 49
BRAND/PRODUCT COMPARISON
FIGURE 50
NUTRACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 51
NUTRACEUTICAL EXCIPIENTS MARKET: COMPANY FOOTPRINT
FIGURE 52
NUTRACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 53
COMPANY VALUATION OF KEY NUTRACEUTICAL EXCIPIENTS MANUFACTURERS
FIGURE 54
EV/EBITDA OF KEY COMPANIES
FIGURE 55
KERRY GROUP PLC: COMPANY SNAPSHOT
FIGURE 56
INGREDION: COMPANY SNAPSHOT
FIGURE 57
BASF SE: COMPANY SNAPSHOT
FIGURE 58
ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT
FIGURE 59
SENSIENT TECHNOLOGIES CORPORATION: COMPANY SNAPSHOT
FIGURE 60
CARGILL, INCORPORATED: COMPANY SNAPSHOT
FIGURE 61
AZELIS: COMPANY SNAPSHOT
FIGURE 62
ASHLAND: COMPANY SNAPSHOT
FIGURE 63
ROQUETTE FRÈRES: COMPANY SNAPSHOT
FIGURE 64
IMCD: COMPANY SNAPSHOT
FIGURE 65
NUTRACEUTICAL EXCIPIENTS MARKET: RESEARCH DESIGN
FIGURE 66
KEY DATA FROM PRIMARY SOURCES
FIGURE 67
BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 68
KEY INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 69
BRIEF OF BOTTOM-UP APPROACH
FIGURE 70
NUTRACEUTICAL EXCIPIENTS MARKET: BOTTOM-UP APPROACH
FIGURE 71
NUTRACEUTICAL EXCIPIENTS MARKET: TOP-DOWN APPROACH
FIGURE 72
BRIEF OF TOP-DOWN APPROACH
FIGURE 73
DATA TRIANGULATION
FIGURE 74
FACTOR ANALYSIS
FIGURE 75
RESEARCH ASSUMPTIONS
FIGURE 76
RESEARCH LIMITATIONS
Growth opportunities and latent adjacency in Nutraceutical Excipients Market